Paper25530833
Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.
Ochocki JD and 1 other. Medchemcomm, 2013. Cited by 57 papers, by iCite.
Cite this record
ConductScience Library. Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections. Papers, record 25530833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25530833
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R01 GM084152 | NIGMS NIH HHS | United States | R01GM084152 | PubMed and NIH |
Source NIH RePORTER
References134
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19587457 | Laminopathies and the long strange trip from basic cell biology to therapy. | J Clin Invest | 2009 | https://conductscience.org/library/papers/19587457 | PubMed |
| 2 | 10377218 | Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationships. | J Med Chem | 1999 | https://conductscience.org/library/papers/10377218 | PubMed |
| 3 | 12702809 | Lamin a truncation in Hutchinson-Gilford progeria. | Science | 2003 | https://conductscience.org/library/papers/12702809 | PubMed |
| 4 | 12590887 | Bisphosphonate mechanism of action. | Curr Rheumatol Rep | 2003 | https://conductscience.org/library/papers/12590887 | PubMed |
| 5 | 7547927 | Binding of prenylated and polybasic peptides to membranes: affinities and intervesicle exchange. | Biochemistry | 1995 | https://conductscience.org/library/papers/7547927 | PubMed |
| 6 | 20103566 | A tagging-via-substrate approach to detect the farnesylated proteome using two-dimensional electrophoresis coupled with Western blotting. | Mol Cell Proteomics | 2010 | https://conductscience.org/library/papers/20103566 | PubMed |
| 7 | 10934645 | Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. | J Bone Miner Res | 2000 | https://conductscience.org/library/papers/10934645 | PubMed |
| 8 | 7592920 | Ras CAAX peptidomimetic FTI-277 selectively blocks oncogenic Ras signaling by inducing cytoplasmic accumulation of inactive Ras-Raf complexes. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7592920 | PubMed |
| 9 | 18198825 | 2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability. | J Med Chem | 2008 | https://conductscience.org/library/papers/18198825 | PubMed |
| 10 | 18308574 | Pivaloyloxymethyl-modified isoprenoid bisphosphonates display enhanced inhibition of cellular geranylgeranylation. | Bioorg Med Chem | 2008 | https://conductscience.org/library/papers/18308574 | PubMed |
| 11 | 14668447 | Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/14668447 | PubMed |
| 12 | 15184648 | Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15184648 | PubMed |
| 13 | 8878829 | Geranylgeranylation of Rab proteins. | Biochem Soc Trans | 1996 | https://conductscience.org/library/papers/8878829 | PubMed |
| 14 | 17117849 | Measurement of the alpha-secondary kinetic isotope effect for the reaction catalyzed by mammalian protein farnesyltransferase. | J Am Chem Soc | 2006 | https://conductscience.org/library/papers/17117849 | PubMed |
| 15 | 21520375 | Structure-guided development of selective RabGGTase inhibitors. | Angew Chem Int Ed Engl | 2011 | https://conductscience.org/library/papers/21520375 | PubMed |
| 16 | 19219049 | Analysis of the eukaryotic prenylome by isoprenoid affinity tagging. | Nat Chem Biol | 2009 | https://conductscience.org/library/papers/19219049 | PubMed |
| 17 | 12714972 | Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. | Nature | 2003 | https://conductscience.org/library/papers/12714972 | PubMed |
| 18 | 15184578 | The RAM1 gene encoding a protein-farnesyltransferase beta-subunit homologue is essential in Cryptococcus neoformans. | Microbiology (Reading) | 2004 | https://conductscience.org/library/papers/15184578 | PubMed |
| 19 | 18256394 | Phenotype and course of Hutchinson-Gilford progeria syndrome. | N Engl J Med | 2008 | https://conductscience.org/library/papers/18256394 | PubMed |
| 20 | 9065406 | Crystal structure of protein farnesyltransferase at 2.25 angstrom resolution. | Science | 1997 | https://conductscience.org/library/papers/9065406 | PubMed |
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42831637 | Screening of a chemogenetic library unveils dual-stage antiplasmodials with low cytotoxicity. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42831637 | PubMed |
| 40911556 | In Vitro synergy of Farnesyltransferase inhibitors in combination with colistin against ESKAPE bacteria. | PLoS One | 2025 | https://conductscience.org/library/papers/40911556 | PubMed |
| 40767769 | In Vivo Metabolic Labeling with an Isoprenoid Probe Reveals APOE Allele-Specific Differences in the Prenylome. | ACS Chem Biol | 2025 | https://conductscience.org/library/papers/40767769 | PubMed |
| 40064612 | Examining Farnesyltransferase Interaction With Cell-Permeable CaaX Peptides and the Role of the CaaX Motif in Biological Activity. | J Pept Sci | 2025 | https://conductscience.org/library/papers/40064612 | PubMed |
| 39730316 | Click Chemistry Methodology: The Novel Paintbrush of Drug Design. | ACS Chem Biol | 2025 | https://conductscience.org/library/papers/39730316 | PubMed |
| 37548452 | Functional screening reveals Toxoplasma prenylated proteins required for endocytic trafficking and rhoptry protein sorting. | mBio | 2023 | https://conductscience.org/library/papers/37548452 | PubMed |
| 35628237 | Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35628237 | PubMed |
| 35515296 | Ni(ii)-catalyzed mono-selective ortho-arylation of unactivated aryl C-H bonds utilizing amino acids as a directing group. | RSC Adv | 2019 | https://conductscience.org/library/papers/35515296 | PubMed |
| 34917041 | Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34917041 | PubMed |
| 34827551 | RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma. | Biomolecules | 2021 | https://conductscience.org/library/papers/34827551 | PubMed |
| 34129857 | Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs. | Biochem Pharmacol | 2022 | https://conductscience.org/library/papers/34129857 | PubMed |
| 33821625 | A Not-So-Ancient Grease History: Click Chemistry and Protein Lipid Modifications. | Chem Rev | 2021 | https://conductscience.org/library/papers/33821625 | PubMed |
| 33801503 | Molecular and Pharmacological Characterization of the Interaction between Human Geranylgeranyltransferase Type I and Ras-Related Protein Rap1B. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33801503 | PubMed |
| 33479604 | Targeting prenylation inhibition through the mevalonate pathway. | RSC Med Chem | 2020 | https://conductscience.org/library/papers/33479604 | PubMed |
| 33382854 | Joining forces: Leveraging novel combination therapies to combat infections with eukaryotic pathogens. | PLoS Pathog | 2020 | https://conductscience.org/library/papers/33382854 | PubMed |
| 33246356 | Structure, catalysis, and inhibition mechanism of prenyltransferase. | IUBMB Life | 2021 | https://conductscience.org/library/papers/33246356 | PubMed |
| 31791942 | Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/31791942 | PubMed |
| 31197034 | The chaperone SmgGDS-607 has a dual role, both activating and inhibiting farnesylation of small GTPases. | J Biol Chem | 2019 | https://conductscience.org/library/papers/31197034 | PubMed |
| 31131706 | Differential requirements of protein geranylgeranylation for the virulence of human pathogenic fungi. | Virulence | 2019 | https://conductscience.org/library/papers/31131706 | PubMed |
| 31052427 | Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31052427 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25530833
GET https://conductscience.org/api/papers/v1/25530833/references?page=2